Interest in the monitoring of eosinophil count as a marker of the response to antimicrobial therapy: In response to Karakonstantis and Dimitra

Int J Infect Dis. 2018 Jan:66:145-146. doi: 10.1016/j.ijid.2017.11.013. Epub 2017 Nov 11.

Authors

Benjamin Davido¹, Aurore Moussiegt², Pierre de Truchis², Jérôme Salomon³, Aurélien Dinh², Guillaume Davido⁴

Affiliations

¹ Maladies Infectieuses, Hôpital Universitaire Raymond-Poincaré, AP-HP, Garches, France. Electronic address: benjamin.davido@aphp.fr.
² Maladies Infectieuses, Hôpital Universitaire Raymond-Poincaré, AP-HP, Garches, France.
³ Maladies Infectieuses, Hôpital Universitaire Raymond-Poincaré, AP-HP, Garches, France; Université Versailles-Saint-Quentin, Versailles, France.
⁴ Hôpital Européen Georges Pompidou, AP-HP, Paris, France.

PMID: 29138010
DOI: 10.1016/j.ijid.2017.11.013

No abstract available

Publication types

Letter
Comment

MeSH terms

Anti-Bacterial Agents
Anti-Infective Agents*
Biomarkers
Eosinophils*
Humans
Leukocyte Count

Substances

Anti-Bacterial Agents
Anti-Infective Agents
Biomarkers